Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer

A significant proportion of non-muscle invasive bladder cancer cases will progress to muscle invasive disease. Transurethral resection followed by Bacillus Calmette Guerin immunotherapy can reduce this risk, while cystectomy prior to muscle invasion provides the best option for survival. Currently,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rangsitratkul, Coby, Lawson, Christine, Bernier-Godon, Francis, Niavarani, Seyedeh-Raheleh, Boudaud, Marie, Rouleau, Samuel, Gladu-Corbin, Antoine-Olivier, Surendran, Abera, Ekindi-Ndongo, Nadia, Koti, Madhuri, Ilkow, Carolina S., Richard, Patrick O., Tai, Lee-Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851153/
https://www.ncbi.nlm.nih.gov/pubmed/35229029
http://dx.doi.org/10.1016/j.omto.2022.01.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851153/
https://www.ncbi.nlm.nih.gov/pubmed/35229029
http://dx.doi.org/10.1016/j.omto.2022.01.009

Ejemplares similares